Covestor’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
JHC
Covestor's CAPR Position: Q3 2026 in Review
Covestor reduced its Capricor Therapeutics (CAPR) stake by 42% in Q3 2026, selling an estimated $89 and leaving 11 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2398.
Covestor first reported a position in CAPR in Q1 2026 and has held it in 3 quarters since. 106 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.
- Covestor held 11 shares of Capricor Therapeutics worth $0 as of Q3 2026.
- Covestor sold 8 Capricor Therapeutics shares in Q3 2026, an estimated $89.
- Capricor Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2398 holding.
- Covestor first reported a position in Capricor Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 106 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.